跳至主要内容
临床试验/NL-OMON54119
NL-OMON54119招募中不适用

COVID-19 in Pediatric Patients: clinical and immunological features - COPP-IMM

eids Universitair Medisch Centrum0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 至 17(—)

入选标准

  • - age up to and including 17 years
  • - clinical or microbiological diagnosis of COVID-19 or MIS-C
  • - presentation in hospital (outpatient department, emergency department, or
  • clinical admission)
  • Study population of the substudy on reinfections: enrolled participants of the
  • initial studies COPP/COPP-IMM will be approached to also participate in the
  • current substudy.
  • Inclusion criteria for this substudy:
  • - Children with a prior COVID-19 infection and/or MIS-C, treated as in- or
  • outpatients in Dutch hospitals, AND
  • - Previously included in the COPP/COPP-IMM study between 1st of March 2020 and
  • 1st of September 2022, with consent to be approached for subsequent studies, AND
  • - Informed consent for the reinfection substudy

排除标准

  • Age 18 years or older
  • No COVID-19 or MIS-C
  • No informed consent
  • For blood sampling: body weight under 3 kg
  • Exclusion criteria for the substudy on reinfections
  • A potential subject who meets any of the following criteria will be excluded
  • - No consent from guardians and/or patient

研究者

相似试验